Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Haematologica|May 30, 2013
Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoterYohann Repessé, Ivan Peyron, Jordan D Dimitrov, et al.Haematologica|March 24, 2018
Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQJohana Hrdinová, Fabian C Verbij, Paul H P Kaijen, et al.Journal of Thrombosis and Haemostasis : JTH|April 21, 2022
Antithrombotic potential of a single-domain antibody enhancing the activated protein C-cofactor activity of protein SJosepha C Sedzro, Frédéric Adam, Claire Auditeau, et al.Research and Practice in Thrombosis and Haemostasis|June 23, 2022
Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterizationMarie-Daniéla Dubois, Ivan Peyron, Olivier-Nicolas Pierre-Louis, et al.Blood Advances|January 4, 2018
The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophagesFabian C Verbij, Nicoletta Sorvillo, Paul H P Kaijen, et al.Haematologica|July 29, 2017
The ADAMTS13<sup>1239-1253</sup> peptide is a dominant HLA-DR1-restricted CD4<sup>+</sup> T-cell epitopeLaurent Gilardin, Sandrine Delignat, Ivan Peyron, et al.Journal of Thrombosis and Haemostasis : JTH|June 4, 2023
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapyAngelina Mimoun, Melissa Bou-Jaoudeh, Sandrine Delignat, et al.Blood|December 23, 2022
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWDClaire Kizlik-Masson, Ivan Peyron, Stéphane Gangnard, et al.Pageof 3